Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

In patients with first relapse of primary ovarian cancer and bevacizumab beyond progression, the prolonged PFS effect of bevacizumab does not seem to affect sensitivity to subsequent platinum-based chemotherapy.

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology Reports
Published
2025-04-09
DOI
https://doi.org/10.1016/j.gore.2025.101740
Citations
1
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
1.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

Iemasa Koh, Atsushi Arakawa, Kimihiko Ito, Kazuhiro Takehara et al.
1 citations
Gynecologic Oncology Reports
Ovarian cancer diagnosis and treatment
1.70
article

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

Iemasa Koh, Atsushi Arakawa, Kimihiko Ito, Kazuhiro Takehara, Tamaki Tanaka, Tomoka Usami, Kotaro Sueoka, Yosuke Konno, Shinya Sato, Eiji Kondo, Masahiro Kagabu, Hiroko Nakamura, Keiichiro Nakamura, Noriomi Matsumura, Satoe Fujiwara, Masako Ishikawa, Kei Hirabayashi, Masato Nishimura, Atsushi Hongo
article en
1 citations

Abstract

In patients with first relapse of primary ovarian cancer and bevacizumab beyond progression, the prolonged PFS effect of bevacizumab does not seem to affect sensitivity to subsequent platinum-based chemotherapy.

Gynecologic Oncology ReportsVol. 59
Hiroshima University (JP), Okayama University (JP), Shimane University (JP), Yamaguchi University (JP), Mie University (JP), Iwate Medical University (JP), Kawasaki Medical School (JP), Kagawa University (JP), Nagoya City University (JP), Tokushima Prefectural Central Hospital (JP), Kansai Rosai Hospital (JP), Shikoku Cancer Center (JP), Nagoya Medical Center (JP), Ehime University (JP), Osaka University of Pharmaceutical Sciences (JP), Kindai University (JP)
Good health and well-being
Openalex Percentile: Top 18%
Ovarian cancer diagnosis and treatment
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.